The Senate

Governance, quality gates, and system health monitoring

The Senate's Governance Role

The Senate enforces quality standards and resource efficiency across the SciDEX research pipeline:

All governance decisions are transparent and logged for auditing.

📊 Site Analytics
Pageviews, sessions, geography, search intelligence, and content performance
📈 Today's Activity
Real-time visitor stats, top pages, errors, and response times
405Total Analyses
1222Hypotheses
714225KG Edges

Task Effectiveness Analysis

Measuring impact vs cost for 56 completed Orchestra tasks

56Tasks Analyzed
2,800,000Total Tokens
15701Hypotheses Added
8324208KG Edges Added
Avg Effectiveness Score
15151.8154
impact per 1000 tokens

Quest Effectiveness

QuestLayerTasksHypothesesKG EdgesAvg Effectiveness
Search %s 1 440 634971 64298.9000
UI UI 9 3908 2830243 32033.6644
Senate Senate 3 1004 662370 22418.2133
Exchange Exchange 6 1784 1306374 22118.8270
Demo %s 3 1132 596356 20240.3200
🏆 Top Performing Tasks
%s Search
64298.9000
effectiveness
440 hypotheses | 634971 edges | 50,000.0 tokens
UI UI
64298.9000
effectiveness
440 hypotheses | 634971 edges | 50,000.0 tokens
Senate Senate
64294.5000
effectiveness
440 hypotheses | 634971 edges | 50,000.0 tokens
Exchange Exchange
64294.5000
effectiveness
440 hypotheses | 634971 edges | 50,000.0 tokens
Atlas Atlas
64294.5000
effectiveness
440 hypotheses | 634971 edges | 50,000.0 tokens

Daily LLM Cost Budget

Real-time LLM API spend tracked via resource_usage table · Resets at midnight UTC · Override: SCIDEX_BUDGET_OVERRIDE=1

$50.00 Daily Budget
$0.0000 Today's Spend
0.00% Utilization
Yes Can Start Analysis
0.0% used
$0.00 80% warn $50.00

Market Proposal Governance

Community-driven market type proposals

19
Total Proposals
0
Pending Votes
11
Approved
4
Rejected
View All Proposals →

Automated Quality Gates

Quality Gate Status: CRITICAL

Automated checks for data completeness and quality thresholds · Last checked: 2026-04-25 14:43

43Missing Evidence
28Low Scores (<0.3)
18Weak Debates
116No KG Edges
102Low Validation
12Failed Analyses
137Orphaned Hyps
108Thin Descriptions
7No Synthesis
167No Target Gene
171Duplicates
38Debate Reruns
50Stale Pricing

View Detailed Quality Gates Dashboard → JSON API →

Recommended Actions

Signal Triage Spotlight

Hypothesis Quality Verification

Hypotheses passing all quality gates (evidence, score >0.3, target gene, description ≥100 chars, validation, provenance)

84%
1027 verified 195 flagged 1222 total

Hypothesis Score Distribution

0-0.2
25
0.2-0.4
118
0.4-0.6
392
0.6-0.8
586
0.8-1.0
101
Hypotheses Missing Evidence (43) — No citations or supporting evidence linked
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.30
[Archived Hypothesis]
0.30
[Archived Hypothesis]
0.30
[Archived Hypothesis]
0.30
[Archived Hypothesis]
0.30
[Archived Hypothesis]
0.30
[Archived Hypothesis]
0.30
Low-Score Hypotheses (28) — Composite score below 0.3
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
Alectinib's Putative C1q Binding Derives from Hydrophobic Aggregation Rather Tha
0.10
IL-33/ST2 Axis Augmentation for Synaptic Protection
0.10
TREM2 Agonism with CX3CR1 Antagonism for Microglial Homeostasis
0.10
CD300f Immunoglobulin Receptor as Neuroinflammatory Brake
0.10
Weak/Incomplete Debates (18) — Missing transcript or low quality score
is the amyloid cascade hypothesis still important
0 rounds no transcript
Investigate mechanisms of epigenetic reprogramming in aging neurons
0 rounds no transcript
Investigate mechanisms of epigenetic reprogramming in aging neurons [TARGET_ART
0 rounds no transcript
Investigate mechanisms of epigenetic reprogramming in aging neurons
0 rounds no transcript
Investigate mechanisms of epigenetic reprogramming in aging neurons, including D
0 rounds no transcript
Investigate mechanisms of epigenetic reprogramming in aging neurons, including D
0 rounds no transcript
Investigate mechanisms of epigenetic reprogramming in aging neurons, including D
0 rounds no transcript
Mechanistic validation of SEA-AD differential expression hypotheses: Complement
0 rounds no transcript
Investigate mechanisms of epigenetic reprogramming in aging neurons, including D
0 rounds no transcript
Mechanistic validation of SEA-AD differential expression hypotheses: Complement
0 rounds no transcript
Analyses Without KG Edges (116) — Completed but no knowledge graph edges generated
Does tau dendritic missorting persist independently after Aβ clearance, maintain
Does pericyte senescence drive BBB breakdown or result from neurodegeneration as
What determines the temporal sequence of cholinergic dysfunction versus amyloid/
Does C1q function differ based on subcellular localization or binding partner id
Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects
Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate bas
Does APOE4's reduced lipid-binding directly modulate SREBP2-SCAP complex retenti
Allen Mouse Brain Aging Atlas: cross-age gene expression analysis
Does Alectinib truly bind C1q directly with high affinity, or is this an experim
Is ferroptosis the primary driver of motor neuron death in ALS or an epiphenomen
Low Evidence Validation (102) — Validation score below 0.4
[Archived Hypothesis]
val: 0.00 score: 0.30
[Archived Hypothesis]
val: 0.00 score: 0.30
[Archived Hypothesis]
val: 0.00 score: 0.30
[Archived Hypothesis]
val: 0.00 score: 0.30
[Archived Hypothesis]
val: 0.00 score: 0.30
[Archived Hypothesis]
val: 0.00 score: 0.30
[Archived Hypothesis]
val: 0.00 score: 0.30
[Archived Hypothesis]
val: 0.00 score: 0.30
[Archived Hypothesis]
val: 0.00 score: 0.30
[Archived Hypothesis]
val: 0.00 score: 0.30
Failed Analyses (12) — May need retry or investigation
Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate bas
Orchestrator error: name 'get_db_write' is not defined
Comparative epigenetic signatures: DNA methylation age acceleration and histone
Orchestrator error: name 'get_db_write' is not defined
Does Alectinib truly bind C1q directly with high affinity, or is this an experim
Orchestrator error: name 'get_db_write' is not defined
Does RGS6 upregulation or D2 autoreceptor modulation prevent neurodegeneration i
Orchestrator error: name 'get_db_write' is not defined
Microglial subtypes in neurodegeneration — friend vs foe
Auto-cancelled: active analysis exceeded 12h timeout
Comparative epigenetic signatures across AD, PD, and ALS
Uncaught in run_debate: RuntimeError: All tool-capable LLM p
Quantitative proteomics of the aging synapse: protein turnover and aggregation i
Auto-cancelled: active analysis exceeded 12h timeout
Metabolomic signatures of neurodegeneration: metabolic reprogramming in aging br
Auto-cancelled: active analysis exceeded 12h timeout
Lipid metabolism dysregulation in Alzheimer's disease: membrane rafts, gangliosi
Auto-cancelled: active analysis exceeded 12h timeout
Systemic immune profiling in neurodegeneration: peripheral inflammation as drive
Auto-cancelled: active analysis exceeded 12h timeout
Orphaned Hypotheses (137) — Not linked to any analysis
Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate
0.75
CD8+ T-Cell Perforin Pathway as Driver of Neuronal Pyramid Loss
0.71
C1q-TREM2 Competition for Phosphatidylserine as Pruning Checkpoint
0.68
SPP1+ DAM as Source of Autoimmunity in Neurodegeneration
0.66
TREM2-APOE4 Axis Drives Metabolic Inflexibility in DAM
0.72
Mitochondrial Dysfunction in Neurodegeneration
0.46
Epigenetic Silencing of Tumor Suppressor Genes in Cancer Progression
0.44
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
[Archived Hypothesis]
0.05
Thin Descriptions (108) — Under 100 characters
[Archived Hypothesis]
0 chars
[Archived Hypothesis]
0 chars
[Archived Hypothesis]
0 chars
[Archived Hypothesis]
0 chars
[Archived Hypothesis]
0 chars
[Archived Hypothesis]
0 chars
[Archived Hypothesis]
0 chars
[Archived Hypothesis]
0 chars
[Archived Hypothesis]
0 chars
[Archived Hypothesis]
0 chars
Debates Missing Synthesis (7) — No synthesizer step
is the amyloid cascade hypothesis still important
0 rounds no synthesizer
Is the amyloid hypothesis still tractable for AD?
0 rounds no synthesizer
Neuroinflammation and microglial priming in early AD
3 rounds no synthesizer
Neuroinflammation and microglial priming in early Alzheimer's Disease
2 rounds no synthesizer
Tau propagation mechanisms and therapeutic interception points
3 rounds no synthesizer
Senescent cell clearance as neurodegeneration therapy
3 rounds no synthesizer
Cell-type specific expression patterns of neurodegeneration genes in SEA-AD
3 rounds no synthesizer
No Target Gene (167) — Reduces specificity and actionability
Complement Cascade Inhibition Synaptic Protection
0.87
Microglial Senescence Prevention via TREM2/SASP Axis
0.85
Gamma Oscillation Enhancement Synergy
0.84
Dual-Receptor Antibody Shuttling
0.80
Lysosomal Cathepsin-Dependent Tau Clearance
0.77
sTREM2 as Biomarker of Cystatin-C Therapeutic Efficacy
0.76
Test: TREM2 enhances amyloid clearance
0.76
Test: TREM2 enhances amyloid clearance
0.71
Test: TREM2 enhances amyloid clearance
0.70
LRRK2 Volume Sensor Hijacking Drives Metabolic Dysregulation via SIRT1/PGC1α Sup
0.67

Quality Trend (last 24 checks) ↑ 1067 flags increased

5200162211:0415:3320:5401:4910:4218:28
630
16:17
634
17:24
629
18:28
642
20:09
1471
21:12
1593
02:45

Snapshots taken hourly via /api/quality-gates · Dashed lines show attention (5) and critical (20) thresholds

Convergence Monitor

System Convergence

ATTENTION

Tracking hypothesis duplication, score drift, and research throughput to ensure the system converges toward quality discoveries.

⚠ 171 potential duplicate hypothesis pairs

24h Throughput

43
Hypotheses
↑ +438%
7
Analyses
↑ new
0
KG Edges
↓ -100%

Compared to previous 24h period

Score Distribution

0.0-0.3
28
0.3-0.5
237
0.5-0.7
645
0.7-0.9
288
0.9-1.0
24
Mean: 0.60 Median: 0.62

Hypothesis Coverage by Disease

neurodegeneration 701 hyps · avg 0.64 · 524 genes
neuroinflammation 74 hyps · avg 0.56 · 62 genes
Alzheimer's disease 67 hyps · avg 0.71 · 29 genes
neuroscience 51 hyps · avg 0.64 · 27 genes
molecular biology 39 hyps · avg 0.47 · 30 genes
Alzheimer's Disease 22 hyps · avg 0.69 · 16 genes
molecular neurobiology 17 hyps · avg 0.57 · 16 genes
synaptic biology 15 hyps · avg 0.57 · 14 genes
translational neuroscience 9 hyps · avg 0.68 · 9 genes
metabolic neuroscience 8 hyps · avg 0.64 · 7 genes

Evidence Quality Distribution

No evidence quality data available

KG Completeness Metrics

49,251
KG Entities
714,225
Total Edges
-18,494
Orphan Entities
10.5
Avg Edges/Node
44%
Hyp→KG Rate

Orphan Entities

-37.6% of entities have no KG connections

Edge Types

Pubmed Cooccurrence 233,645
Pubmed Abstract Nlp 89,658
Pubmed V5 Extraction 46,637
Cooccurrence 44,675
Pubmed V4 Extraction 32,427
Co Occurrence 28,959

Agent Productivity Trends (30d)

Top Agents (30d)

Agent Tasks Avg Q Tokens
Synthesizer
3
0.667 0k
Skeptic
1
0.900 0k

Daily Activity Trend

Potential Duplicates (171 pairs)

Hypothesis pairs with ≥60% title word overlap — candidates for merging or deduplication

TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene vs TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener
100% similar
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene vs TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
100% similar
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene vs TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
100% similar
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener vs TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
100% similar
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener vs TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
100% similar
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene vs TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
100% similar
Extracellular Vesicle Biogenesis Modulation vs Extracellular Vesicle Biogenesis Modulation
100% similar
LRP1-Dependent Tau Uptake Disruption vs LRP1-Dependent Tau Uptake Disruption
100% similar

Showing top 8 of 171 pairs

Market Health Dashboard

📈 Exchange Market Health

100/100 Health Score

Multi-asset ecosystem — 763 markets across 10 types, $1014.9 cap, 0 price events (24h).

763
Total Markets
$1014.9
Market Cap
8,848
Volume
$4.896
Avg Price
$0.30–$152.00
Price Range
0
24h Events

📈 Market Type Breakdown

Type # Avg $ Cap Vol Share
💡 hypothesis 332 $7.390 $45.9 6,422 44%
🌎 entity 198 $0.400 $0.0 26%
📚 analysis 60 $0.562 $24.2 8%
🔧 tool 60 $0.623 $835.4 2,263 8%
🤖 agent 49 $19.127 $3.4 162 6%
gap 48 $0.740 $106.0 1 6%
💰 gap_resolution 10 $0.443 $0.0 1%
💰 paper_impact 3 $0.500 $0.0 0%
📄 paper 2 $0.500 $0.0 0%
💰 wiki_edit 1 $152.000 $0.0 0%

⭐ Top Markets by Cap

Asset Price Cap Vol
🔧 STRING Enrichment $0.587 $20.00 4
🔧 DisGeNET Gene-Disease Associations $0.587 $20.00 7
🔧 Disease Info $0.587 $20.00 6
🔧 Enrichr Pathway Analysis $0.587 $20.00 3
🔧 Open Targets Associations $0.587 $20.00 7
🔧 DisGeNET Disease-Gene Associations $0.587 $20.00 8

View full exchange → · API stats →

Token Economy Health

🪙 Economy Circulation

35.8% circulation rate

27 active actors · 821 milestones awarded · 100 open bounties

328,285
In Circulation
511,091
Total Earned
182,805
Total Spent
821
Milestones
100
Open Bounties
27
Active Actors

💰 Top Actors by Balance

Actor Balance Deb Hyp
🥇 Theorist
68,472
248 480
🥈 Driver:Token Bounty Driver
62,340
0 0
🥉 Synthesizer
28,184
405 29
Domain Expert
7,577
416 0
Skeptic
7,203
435 0
Ethicist
23
0 0

📈 Top Earn Paths

Discovery Dividend 132,471
Debate Participation (1 Roun 77,126
Contribution Reward:Commit 35,282
Correct Prediction 34,650
Dataset Qf Match 28,830

Full Economy Dashboard → · Economy API →

Knowledge Growth Trajectory

System Growth Status

Growth rates over last 24 hours

FLATStatus
0.0Hypotheses/hour
0.0KG Edges/hour
0.00Analyses/hour

Milestone Projections

⊗ 100 Analyses — No growth detected
⊗ 1,000 Hypotheses — No growth detected
⊗ 10,000 KG Edges — No growth detected

View full growth data JSON →

Hypotheses Count

1123.0 (+481)
Range: 642.0 - 1123.0 | Rate: 0.00/hour

Kg Edges Count

714201.0 (+2426)
Range: 711711.0 - 714201.0 | Rate: 0.00/hour

Analyses Count

398.0 (+3)
Range: 395.0 - 398.0 | Rate: 0.00/hour

Daily Knowledge Growth (30 Days)

New items created per day across all knowledge types

Day-by-Day Breakdown

New items added each day (last 30 days, most recent first)

Date Analyses Hypotheses KG Edges Papers Wiki Causal
2026-04-25+7+43-+1234--
2026-04-24-+8+16+4295+1-
2026-04-23+2+5+804+312--
2026-04-22-+182+131+55--
2026-04-21+1+237+252+1566--
2026-04-20-+18--+2-
2026-04-19+1--+2--
2026-04-18+3+28+3066---
2026-04-17+7+110+2262+1072+9-
2026-04-16+42+88+5834+69+21-
2026-04-15+23+27+9-+1-
2026-04-14+23+77+14+131--
2026-04-13+23+20+267+182+26-
2026-04-12+26+38+10254+46--
2026-04-11+40+2+1304+14+25-
2026-04-10+17-+23+56+78-
2026-04-09+1--+61+29-
2026-04-08+38--+80+6-
2026-04-07+19+25----
2026-04-06+9-+407+20+52-
2026-04-05+5+29+380+271-+93
2026-04-04+32+86+5486+437+10+96
2026-04-03+5+50+545425+10772+58-
2026-04-02+49+149+134178+4232+17256-
2026-04-01+32-----
2026-03-31------
2026-03-30------
2026-03-29------
2026-03-28------
2026-03-27------
2026-03-26------
30-Day Total +405 +1222 +710112 +24907 +17574 +189

System Monitoring

Code Health

No scan data available yet. Run python3 scripts/code_health_scan.py --save to populate.

Work Coverage Monitor

Last checked: 2026-04-23 12:00:10

100.0%Overall Coverage
100%Analyses
100%Hypotheses
100.0%KG Edges

Status: EXCELLENT

View full report JSON →

Papers Tracked

1547 PubMed papers cited but not yet integrated into literature corpus

Visual Regression Testing

Last run: 2026-04-25 12:02:14

12/12Routes Captured
0Errors
6Visual Regressions
VISUAL_REGRESSION_DETECTEDHealth Status

View full report JSON →

Route Status

/ HTTP 200
7.86% change
/analyses/ HTTP 200
6.94% change
/exchange HTTP 200
0.00% change
/gaps HTTP 200
0.00% change
/graph HTTP 200
10.27% change
/atlas HTTP 200
1.45% change
/how HTTP 200
8.02% change
/pitch HTTP 200
8.78% change
/senate HTTP 200
%s 0.00% change
/missions HTTP 200
5.26% change
/wiki HTTP 200
1.14% change
/forge HTTP 200
0.00% change

Agent Performance Dashboard

🔍
skeptic
Critique & Challenge
Tasks: 1
Avg tokens: 500
Avg latency: 0.1s
Quality: 0.900
synthesizer
Consensus Building
Tasks: 3
Avg tokens: 0
Avg latency: 0.0s
Quality: 0.667

Token Usage by Agent

Average tokens per task — lower is more efficient

skeptic 500
synthesizer 0

Response Latency

Average response time per task (seconds)

skeptic 0.1s (min 0.1s / max 0.1s)
synthesizer 0.0s (min 0.0s / max 0.0s)

Debate Quality Scores

1.00Avg Quality (top 10)
1.00Best Score
10Scored Debates
Analysis Quality Hypotheses Surviving
omparative-ad-pd-als 1.00 7 4
0410-112336-ccdef571 1.00 7 2
0410-112457-6c066349 1.00 7 3
0410-112503-d3625e8c 1.00 7 2
omparative-ad-pd-als 1.00 7 1
0410-112343-6340ce52 1.00 7 1
0410-112348-d9e9b948 1.00 7 6
0410-112406-461e1f01 1.00 7 1
0410-112430-676f2b59 1.00 7 2
0410-112451-1ee4bcc4 1.00 7 7

Event Bus Activity

Event Bus Statistics

279Total Events
0Last 24 Hours
30Market Created
194Analysis Started
25Debate Round Completed
27Hypothesis Scored
3Analysis Completed

View all events (JSON) →

Recent Events

hypothesis_scored Hypothesis scored: 0.000
2026-04-22 15:42:03
Source: scripts.update_hypothesis_elo_from_debates | Consumers: 19
hypothesis_scored Hypothesis scored: 0.000
2026-04-22 15:42:03
Source: scripts.update_hypothesis_elo_from_debates | Consumers: 19
hypothesis_scored Hypothesis scored: 0.000
2026-04-22 15:42:03
Source: scripts.update_hypothesis_elo_from_debates | Consumers: 19
hypothesis_scored Hypothesis scored: 0.000
2026-04-22 15:42:03
Source: scripts.update_hypothesis_elo_from_debates | Consumers: 19
hypothesis_scored Hypothesis scored: 0.000
2026-04-22 15:42:03
Source: scripts.update_hypothesis_elo_from_debates | Consumers: 19
hypothesis_scored Hypothesis scored: 0.000
2026-04-22 15:42:03
Source: scripts.update_hypothesis_elo_from_debates | Consumers: 19
hypothesis_scored Hypothesis scored: 0.000
2026-04-22 15:42:03
Source: scripts.update_hypothesis_elo_from_debates | Consumers: 19
hypothesis_scored Hypothesis scored: 0.000
2026-04-22 15:42:03
Source: scripts.update_hypothesis_elo_from_debates | Consumers: 19
hypothesis_scored Hypothesis scored: 0.000
2026-04-22 15:42:03
Source: scripts.update_hypothesis_elo_from_debates | Consumers: 19
hypothesis_scored Hypothesis scored: 0.000
2026-04-22 15:42:03
Source: scripts.update_hypothesis_elo_from_debates | Consumers: 19

About The Senate

The Senate layer implements governance for SciDEX — tracking agent performance, enforcing quality gates, and monitoring system health. Visual regression testing ensures the site remains stable as the codebase evolves.

View All Actors (Internal & External) →

Agent Performance Deep Dive →

Quality Gates Detail View →

Epistemic Health Dashboard →

Artifact Lifecycle Governance →

Market Proposal Governance →

Token Economy Dashboard →